These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 19157506

  • 1. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
    Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B.
    Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
    [Abstract] [Full Text] [Related]

  • 2. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B.
    Cancer; 2007 Jan 15; 109(2):228-38. PubMed ID: 17167759
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
    Dong HP, Holth A, Kleinberg L, Ruud MG, Elstrand MB, Tropé CG, Davidson B, Risberg B.
    Am J Clin Pathol; 2009 Nov 15; 132(5):756-62. PubMed ID: 19846818
    [Abstract] [Full Text] [Related]

  • 4. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
    Davidson B, Shih IeM, Wang TL.
    Hum Pathol; 2008 Nov 15; 39(11):1630-6. PubMed ID: 18656238
    [Abstract] [Full Text] [Related]

  • 5. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov 15; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 6. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B.
    Int J Gynecol Pathol; 2009 May 15; 28(3):211-21. PubMed ID: 19620938
    [Abstract] [Full Text] [Related]

  • 7. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May 15; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 8. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
    Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC.
    Cancer; 2004 May 15; 100(10):2139-47. PubMed ID: 15139056
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B.
    Hum Pathol; 2009 Apr 15; 40(4):527-37. PubMed ID: 19121847
    [Abstract] [Full Text] [Related]

  • 10. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
    Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B.
    Gynecol Oncol; 2013 May 15; 129(2):358-63. PubMed ID: 23438671
    [Abstract] [Full Text] [Related]

  • 11. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
    Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA.
    Clin Cancer Res; 2003 Jun 15; 9(6):2248-59. PubMed ID: 12796393
    [Abstract] [Full Text] [Related]

  • 12. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.
    Kleinberg L, Holth A, Trope CG, Reich R, Davidson B.
    Hum Pathol; 2008 May 15; 39(5):747-57. PubMed ID: 18439941
    [Abstract] [Full Text] [Related]

  • 13. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec 15; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 14. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
    Kleinberg L, Flørenes VA, Nesland JM, Davidson B.
    Am J Clin Pathol; 2007 Sep 15; 128(3):389-97. PubMed ID: 17709312
    [Abstract] [Full Text] [Related]

  • 15. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B, Baekelandt M, Shih IeM.
    Diagn Cytopathol; 2007 Dec 15; 35(12):756-60. PubMed ID: 18008338
    [Abstract] [Full Text] [Related]

  • 16. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer.
    Guo RX, Qiao YH, Zhou Y, Li LX, Shi HR, Chen KS.
    Pathol Int; 2008 Dec 15; 58(12):749-56. PubMed ID: 19067848
    [Abstract] [Full Text] [Related]

  • 17. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.
    Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM.
    Hum Pathol; 2011 Jul 15; 42(7):991-7. PubMed ID: 21315424
    [Abstract] [Full Text] [Related]

  • 18. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
    Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA.
    Gynecol Oncol; 2001 Nov 15; 83(2):249-56. PubMed ID: 11606079
    [Abstract] [Full Text] [Related]

  • 19. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
    Wu W, Pan C, Yu H, Gong H, Wang Y.
    J Gastroenterol Hepatol; 2008 Mar 15; 23(3):491-7. PubMed ID: 17524042
    [Abstract] [Full Text] [Related]

  • 20. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
    Elstrand MB, Stavnes HT, Tropé CG, Davidson B.
    Hum Pathol; 2012 Apr 15; 43(4):529-35. PubMed ID: 21864883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.